Medical Design Briefs - October 2022 - 22

MANAGING DIGITAL OUTCOMES AND SENSORS COUPLED WITH AI
2:00 PM
Pairing Remote EEG Monitoring with Large-Scale Computing to Go Beyond the Analysis Capabilities of Human Experts
* Wearable biosensors will provide scalable continuous brain health metrics to accelerate precision medicine for patients
with severe neurological disease.
* The rise of machine learning and improvement in wearable sensor technologies has created a unique moment in time
where EEG will become scalable in a way that was never possible with traditional hardware and expert-dependent interpretation.
*
Novel machine learning algorithms and large clinical datasets are poised to transform how brain disorders are treated.
Using clinical-grade data from remote EEG monitoring, machine learning accelerates the discovery of neurobiomarkers
and the development of new treatments for patients with neurological, psychiatric or sleep disorders.
* Neurobiomarkers are helping to progress new discoveries from development to targeted deployment into clinical trials
and novel therapeutic areas.
Speaker: Jacob Donoghue, CEO & Co-Founder, Beacon Biosignals
2:40 PM
What's New in Wearable Biosensors and AI/ML-Based Remote Patient Management
* How artificial intelligence (AI)/machine learning (ML) coupled with biosensors can improve drug safety and efficacy
* How Chugai and Biofourmis are leveraging wearables and AI/ML to identify objective measures of pain in clinical studies
* Ten years after the first patient was treated with CAR-T therapy: Sensors and predictive analytics monitor patients'
post-treatment to prevent life-threatening issues
* Future clinical and therapeutic potential of AI/ML coupled with biosensors
Speaker: Jaydev Thakkar, COO, Biofourmis
3:20 PM
3:50 PM
Afternoon Tea
PANEL DISCUSSION
Clinical Value and Utility of Advancements in Remote Care Technologies
* Exploring the fast-growing capabilities of wearables in the clinic as a result of developments in technologies
* How are monitoring technologies being used to evolve a standard of care within the walls of hospitals and health system
facilities?
* How can data driven continuous care models start to automate care?
* The ongoing pathway of monitoring patients with complex care needs
Panel Moderator: James Mault, MD, Founder and CEO, BioIntelliSense, Inc.
4:30 PM
Tales from the Trenches
* Considerations in commercializing health technology
* Incorporating meaningful data for adoption
* Data integration and data flows for healthcare decision making
* Strategic planning and evidence building discussion
Speaker: Kate Gunning, Managing Partner, Focus Academy LLC
5:50 PM
Chairs' Closing Remarks and Close of Day 2
SPONSORED BY: RAUMEDIC
www.raumedic.com
Together with its customers, the medical technology company
is breaking new ground to improve the diagnosis and treatment
of diseases. In doing so, Raumedic focuses on polymerbased
solutions for medical and pharmaceutical applications, as
well as on products for intensive care. Raumedic has a global
presence and a headcount of approximately 1,000. In its core
markets of Europe and North America, the company manufactures
using its own cleanroom production facilities.
OPENING ADDRESS DAY 1:
Medical-Grade Wearables and Continuous Remote Monitoring from In-Hospital to Home
* A new generation of medical grade wearable sensors can enable
continuous multi-parameter patient monitoring both
in-hospital and at-home.
* With the effortless simplicity of passive continuous monitoring,
the asynchronous data streams generated by these wearable
devices, combined with scalable exception management
algorithms, enable more proactive, efficient, and
scalable models of care.
* These new remote care technology solutions can reduce
length of stay, detect negative trends early in their course,
and deliver better care to more patients at a fraction of
the cost.
22
James Mault, MD, Founder and CEO,
BioIntelliSense, Inc.
James Mault, MD, FACS, is the founder
and chief executive officer of BioIntelliSense,
a data-as-a-service (DaaS)
platform company, delivering breakthrough
medical-grade biosensor technology
with unique clinical intelligence
for scalable remote patient monitoring.
Prior
to
www.medicaldesignbriefs.com
BioIntelliSense, Dr.
Medical Design Briefs, October 2022
Mault
served as senior vice president and chief medical officer of
Qualcomm Life for over five years, where his leadership respon
http://www.raumedic.com http://www.medicaldesignbriefs.com
Medical Design Briefs - October 2022

Table of Contents for the Digital Edition of Medical Design Briefs - October 2022
